AGE AND OUTCOMES FOLLOWING GUIDED DE-ESCALATION OF ANTIPLATELET TREATMENT IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS OF A RANDOMIZED MULTICENTRE TRIAL

Guided de-escalation of antiplatelet treatment with a switch from prasugrel to clopidogrel was identified recently as an effective alternative strategy in ACS patients undergoing PCI in the TROPICAL-ACS trial. Safety and efficacy of such a strategy may differ in relation to patient's age. This pre-